MMI lands ~EUR 116m to scale Symani
Italian surgical robotics specialist Medical Microinstruments raised $125 million (~EUR 116m) in a Series D led by BioStar Capital, with S3 Ventures and Angelini Ventures participating.
Sector
Healthcare M&A
Healthcare M&A activity spans pharmaceuticals, biotechnology, medical devices, and healthcare services. The sector attracts both strategic consolidators seeking scale and private equity investors focused on platform building in specialized segments.
- Deals · 12mo
- 113
- Disclosed volume
- €8.6B
- Top investor
- Ada Ventures
- Top region
- EU
Latest news
Garofalo buys Malatesta Novello for EUR 69.3m
Garofalo Health Care has acquired Casa di Cura Malatesta Novello in Cesena for EUR 69.3 million, extending its Emilia-Romagna footprint as consolidation among SSN-accredited operators continues.
Dialybrid raises EUR 15m to advance Silkothane graft
Italian vascular-access medtech Dialybrid has closed a EUR 15 million Series A led by XGEN Venture with CDP Venture Capital participation, funding a first-in-human trial of its Silkothane arteriovenous graft and broader preclinical work.
Sensible Biotechnologies raises EUR 47 million
Bratislava-based Sensible Biotechnologies has secured EUR 47 million to scale its VECTOR platform for cell-based mRNA production, combining venture backing with non-dilutive public funding.
Arcus agrees to acquire Germany’s SK Pharma
Arcus has agreed to buy German healthcare company SK Pharma from SYZ Capital and Saturnus Capital. Financial terms were not disclosed.
Duke Street exits Kent Pharma to Phoenix Labs
Duke Street has agreed to sell UK pharma distributor Kent Pharma to Phoenix Labs. Financial terms were not disclosed.
Tandem Health lands ~EUR 93m to scale clinical AI
Sweden’s Tandem Health has raised $100 million (~EUR 93m) Series B led by EU-backed Scaleup Europe Fund, with Kinnevik, Northzone and others re-upping. The round backs faster European rollout of its clinical AI platform.
EIB backs Tensive with EUR 20m venture debt
The European Investment Bank is providing up to EUR 20 million of InvestEU-backed convertible venture debt to Italian clinical-stage medtech Tensive, targeting women’s health and post-breast-cancer breast reconstruction.
Tandem Health raises EUR 86.5 million Series B
Stockholm-based Tandem Health has raised EUR 86.5 million in Series B funding led by EQT-managed Scaleup Europe Fund, with Kinnevik, Northzone and others participating, to expand its AI medical assistant across Europe.
Investindustrial-backed Omnia buys three pharma suppliers
Investindustrial 7-backed Omnia Technologies has acquired Italy-based BRAM-COR, Siempharma and C.Matic. Financial terms were not disclosed.
IRIS, Five Arrows back Implicity in EUR 35m round
French remote cardiac monitoring player Implicity has raised EUR 35 million from IRIS and Five Arrows. The deal underlines sustained investor appetite for clinical-grade remote patient monitoring and decision support in Europe.
BII allocates EUR 7.8m to six spinouts
BioInnovation Institute is funding six Danish early-stage spinouts with EUR 7.8 million in convertible loans and moving them into its 18-month Venture House programme to prepare for external financing.
iPremom raises EUR 15m seed for pregnancy diagnostics
Valencia-based iPremom has raised EUR 15 million in a seed round led by Amadeus Capital Partners, with Asabys Partners and APEX Ventures participating, to advance early pregnancy risk detection testing.
Science4Beauty raises EUR 1.6m from 4growth VC
Polish healthcare venture Science4Beauty has secured a EUR 1.6 million funding round backed by 4growth VC and Hard2beat. Terms, valuation, and use of proceeds were not disclosed.
Plastiflex buys Italy’s Sidam in strategic exit
Mindful Capital Partners and minority shareholder Berrier Capital have exited Italian single-use medical devices maker Sidam via a sale to Plastiflex Group, strengthening the buyer’s fluid-management platform.
Pharosyn raises EUR 2.5m for pharma intel
UK healthcare startup Pharosyn has secured EUR 2.5 million in funding to build a competitive-intelligence platform for pharmaceutical teams. Moonfire, Entrepreneurs First, Transpose Platform and General Advance participated.
Highland Europe leads EUR 40m Adaptyv Series A
Swiss AI-biotech Adaptyv Bio raised EUR 40 million in a Series A led by Highland Europe, with ACE Ventures, byFounders and Y Combinator participating. The round underscores Europe’s continued capital concentration into AI-native life-science platforms.
Radiology Partners to buy Everlight Radiology
Whistler Capital-backed Radiology Partners has agreed to acquire Everlight Radiology from Livingbridge, adding an established UK-led international teleradiology network to its platform. Terms were not disclosed.
Columna Capital exits Ardentis to Medbase
Columna Capital has exited Swiss dental platform Ardentis Cliniques Dentaires in an undisclosed transaction, selling a majority stake to Medbase. The deal extends consolidation momentum in French-speaking Switzerland’s dental market.
Mironid raises EUR 55.42m for rare kidney disease
UK healthcare company Mironid has secured EUR 55.42 million in funding from a syndicate including the Scottish National Investment Bank and Roche Venture Fund to advance a therapy for rare kidney disease.